Acta Scientific Orthopaedics (ISSN: 2581-8635)

Review Article Volume 6 Issue 1

Epidemology and Pathophysiology of Spinal Cord Injury and Potential Health Benefits of Omega 3 Fatty Acid

Rajeshwar Nath Srivastava1*, Zeenat Ara1, Shah Waliullah1, Alka Singh1, Saloni Raj1 and Lavini Raj2

1Department of Orthopaedic Surgery, King George’s Medical University, Shahmina Road, Chowk, Lucknow, Uttar Pradesh, India
2Hult International Business School, USA

*Corresponding Author: Rajeshwar Nath Srivastava, Department of Orthopaedic Surgery, King George’s Medical University, Shahmina Road, Chowk, Lucknow, Uttar Pradesh, India.

Received: October 07, 2022; Published: December 15, 2022

Abstract

Spinal cord injury is a life changing threatening neurological condition that completely changes subject’s life. In medical management recent advances has significantly improved diagnosis, stabilization, survival rate and well-being of SCI patients, but there has been very small progression in its treatment, and some such as Stem cell transplantation etc. is very cost effective that is not possible for everyone to afford, so now a days major focus is on nutraceutical supplementation as they are easy to administer and easy to afford, omega 3 fatty acid are important polyunsaturated fatty acids with some roles in normal cellular metabolism, they have Anti-inflammatory and antioxidant properties, and studies have proved its beneficial role in ameliorating inflammation in different diseases and thus plays role in improving neurological outcomes after neuronal injury, studies have shown that in SCI inflammatory events results in activating various inflammatory markers so PUFA 3 helps in suppressing their activity, for healthy adults, the daily recommended level of omega‐3 fatty acid is 300 mg, Leukotriene‐5, thromboxane‐3, and prostaglandin‐3 are derived from essential fatty acids, and are known to be therapeutically important in inflammatory conditions as well as for mental health.
Omega 3 fatty acid helps in modulating multiple pathways that responsible for damage caused after secondary SCI, due to significant health benefits consumption of EPA and DHA is promoted as fatty fishes such as salmon, mullet, and mackerel are the best sources of EPA and DHA so more focus is on aquaculture industries, thus this review tries to cover all possible potential benefits of PUFA. Omega 3 fatty acid helps in modulating multiple pathways that responsible for damage caused after secondary SCI, due to significant health benefits consumption of EPA and DHA is promoted as fatty fishes such as salmon, mullet, and mackerel are the best sources of EPA and DHA so more focus is on aquaculture industries, thus this review tries to cover all possible potential benefits of PUFA.

Keywords: Osteoporosis; Omega 3 Fatty Acid; SCI; EPA; DHA; National Spinal Cord Injury Statistical Centre (NSCISC)

References

  1. Tator CH. “Biology of neurological recovery and functional restoration after spinal cord injury”. Neurosurgery 42 (1998): 696-707.
  2. Hachem LD., et al. “Assessment and management of acute spinal cord injury: from point of injury to rehabilitation”. The Journal of Spinal Cord Medicine 40 (2017): 665-675.
  3. “Spinal Cord Injury”. WHO, Fact sheet N◦ 384 (2013).
  4. Stein DM., et al. “Emergency neurological life support: traumatic spine injury”. Neurocritical Care 23 (2015): 155-164.
  5. Wilson JR., et al. “Clinical predictors of neurological outcome, functional status, and survival after traumatic spinal cord injury: a systematic review”. Journal of Neurosurgery: Spine (2012): 11-26.
  6. Middleton JW., et al. “Life expectancy after spinal cord injury: a 50-year study”. Spinal Cord (2012): 803-811.
  7. Shavelle RM., et al. “Mobility, continence, and life expectancy in persons with Asia Impairment Scale Grade D spinal cord injuries”. American Journal of Physical Medicine and Rehabilitation 94 (2015): 180-191.
  8. Prasad P., et al. “Plant-based stearidonic acid as sustainable source of omega-3 fatty acid with functional outcomes on human health”. Critical Reviews in Food Science and Nutrition 10 (2021): 1725-1237.
  9. Rubio-Rodríguez N., et al. “Production of omega-3 polyunsaturated fatty acid concentrates: A review”. Innovative Food Science and Emerging Technologies 11 (2010): 1-2.
  10. WHO/FAO. “Fats and oils in human nutrition”. FAO (1994).
  11. Fernández-SanJuan PM. “Fatty acid composition of commercial Spanish fast food and snack food”. Journal of Food Composition and Analysis 13 (2000): 275-281.
  12. Kamei M., et al. “Nutritional evaluation of Japanese take-out lunches compared with Western-style fast foods supplied in. Japan”. Journal of Food Composition and Analysis 15 (2002): 35-45.
  13. Ambring A., et al. “Mediterranean-inspired diet lowers the ratio of serum phospholipids n-6 to n-3 fatty acids, the number of leukocytes and platelets and vascular endothelial growth factor in healthy subjects”. American Journal of Clinical Nutrition 83 (2006): 575-581.
  14. Figueroa JD and Cordero K. “Dietary omega-3 polyunsaturated fatty acids improve the neurolipidome and restore the DHA status while promoting functional recovery after experimental spinal cord injury”. Journal of Neurotrauma 30 (2013): 853-868.
  15. Sabour H., et al. “Omega-3 fatty acids’ effect on leptin and adiponectin concentrations in patients with spinal cord injury: A double-blinded randomized clinical trial”. Journal of Spinal cord Medicine 1 (2015): 599-606.
  16. Ding Y and Chen Q. “mTOR pathway: A potential therapeutic target for spinal cord injury”. Biomedicine and Pharmacotherapy 145 (2022): 112430.
  17. Noble LJ., et al. “Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events”. The Journal of Neuroscience 22 (2002): 7526-7535.
  18. Arabi B., et al. “Extent of Spinal Cord Decompression in Motor Complete (American Spinal Injury Association Impairment Scale Grades A and B) Traumatic Spinal Cord Injury Patients: Post-Operative Magnetic Resonance Imaging Analysis of Standard Operative Approaches”. Journal of Neurotrauma 36 (2019): 862-876.
  19. Chhabra HS., et al. “In-hospital mortality in people with complete acute traumatic spinal cord injury at a tertiary care center in India-a retrospective analysis”. Spinal Cord 25 (2021): 1-6.
  20. Jha RK and Gupta R. “Traumatic Spinal Cord Injury, an Overview of Epidemiology and Management in Vindhya Region”. Executive Editor 12 (2021): 304.
  21. Sengupta D., et al. “Respiratory morbidity and mortality of traumatic cervical spinal cord injury at a level I trauma center in India”. Spinal Cord Series and Cases 13 (2021): 1-8.
  22. JAin M., et al. “Traumatic spine injuries in Eastern India: A retrospective observational study”. International Journal of Critical Illness and Injury Science 11 (2021): 79.
  23. Rai S and Ganvir S. “A retrospective study of demographic profile of patients with spinal cord injury admitted in a tertiary care hospital in Ahmadnagar, India”. International Journal of Physiotherapy and Research 7 (2019): 1034-1039.
  24. Nirmala BP., et al. “Clinical and sociodemographic profiles of persons with spinal cord injury”. Journal of Family Medicine and Primary Care 9 (2020): 4890.
  25. Krishnamurthy G and Kumar G. “A hospital based cross-sectional study on clinical profile of patients with spinal cord injuries”. MRIMS Journal of Health Sciences 1 (2020): 61.
  26. Yusuf AS., et al. “Clinical characteristics and challenges of management of traumatic spinal cord injury in a trauma center of a developing country”. Journal of Neurosciences in Rural Practice 10 (2019): 393-399.
  27. Aswani Kumar K., et al. “Demographic Pattern, Clinical Profile and Outcome of Traumatic Spinal Cord Injuries at a Tertiary care Hospital”. Romanian Neurosurgery (2015): 3.
  28. Ning GZ., et al. “Epidemiology of traumatic spinal cord injury in Asia: a systematic review”. Journal of Spinal Cord Medicine 1 (2012): 229-239.
  29. Chacko V., et al. “Management of spinal cord injury in a general hospital in rural India”. Spinal Cord 24 (1986): 330-335.
  30. Sridharan N., et al. “Epidemiologic evidence of spinal cord injury in Tamil Nadu, India”. International Journal of Research in Medical Sciences 3 (2015): 220-223.
  31. Pandey V., et al. “Care of posttraumatic spinal cord injury patients in India: an analysis”. Indian Journal of Orthopaedics 41 (2007): 295-299.
  32. Lalwani S., et al. “Mortality profile of patients with traumatic spinal injuries at a level I trauma care centre in India”. Indian Journal of Medical Research 140 (2014): 40.
  33. Chen J., et al. “Epidemiological features of traumatic spinal cord injury in Guangdong Province, China”. The Journal of Spinal Cord Medicine 4 (2021): 276-281.
  34. Kim HS., et al. “Epidemiology of spinal cord injury: changes to its cause amid aging population, a single center study”. Annals of Rehabilitation Medicine 45 (2021): 7.
  35. Johansson E., et al. “Epidemiology of traumatic spinal cord injury in Finland”. Spinal Cord 59 (2021): 761-768.
  36. Shehab R., et al. “Role of Omega-3 Fatty Acid in Childbearing Age Women with Vitamin D Deficiency in Sana’a City”. International Journal of Pharmaceutical Investigation 31 (2021): 118-1022.
  37. Matsumura K., et al. “Omega-3 fatty acid intake during pregnancy and risk of infant maltreatment: a nationwide birth cohort-the Japan Environment and Children's Study”. Psychological Medicine 25 (2021): 1-10.
  38. Dangardt F., et al. “Omega-3 fatty acid supplementation improves vascular function and reduces inflammation in obese adolescents”. Atherosclerosis 2 (2010): 580-585.
  39. Zhang Z., et al. “Dietary intakes of EPA and DHA omega-3 fatty acids among US childbearing-age and pregnant women: an analysis of NHANES 2001-2014”. Nutrients 416 (2018): 416.
  40. NA Silva., et al. “From basics to clinical: a comprehensive review on spinal cord injury”. Progress in Neurobiology 114 (2014): 25-57.
  41. Rajaei E., et al. “The effect of omega-3 fatty acids in patients with active rheumatoid arthritis receiving DMARDs therapy: double-blind randomized controlled trial”. Global Journal of Health Science 8 (2015): 18-25.
  42. Miles EA and Calder PC. “Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis”. British Journal of Nutrition 107 (2012): 171-184.
  43. Goldberg RJ and Katz J. “A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain”. Pain 129 (2007): 210.
  44. Qi P., et al. “Lipidomic analysis enables prediction of clinical outcomes in burn patients”. Scientific Reports 6 (2016): 38707.
  45. Lukaschek K., et al. “Cognitive impairment is associated with a low omega-3 index in the elderly: results from the KORA-age study”. Dementia and Geriatric Cognitive Disorders 42 (2016): 236-245.
  46. Berbert AA., et al. “Supplementation of fish oil and olive oil in patients with rheumatoid arthritis”. Nutrition 21 (2005): 131-136.
  47. Kew S., et al. “Effects of oils rich in eicosapentaenoic and docosahexaenoic acids on immune cell composition and function in healthy humans”. The American Journal of Clinical Nutrition 79 (2004): 674-681.
  48. Ayalew-Pervanchon A., et al. “Long-term effect of dietary α-linolenic acid or decosahexaenoic acid on incorporation of decosahexaenoic acid in membranes and its influence on rat heart in vivo”. The American Journal of Physiology-Heart and Circulatory Physiology 293 (2007): 2296-304.
  49. Moghadam A., et al. “Efficacy of omega-3 fatty acid supplementation on serum levels of tumour necrosis factor-alpha, C-reactive protein, and interleukin-2 in type 2 diabetes mellitus patients”. Singapore Medical Journal 53 (2012): 615-619.
  50. Mori TA., et al. “34 (1999): 253-260.
  51. F Shahidi and P Ambigaipalan. “Omega-3 polyunsaturated fatty acids and their health benefits”. Annual Review of Food Science and Technology1 (2018): 345-381.
  52. Patel A., et al. “Bioprospecting of thraustochytrids for omega-3 fatty acids: A sustainable approach to reduce dependency on animal sources”. Trends in Food Science and Technology (2021): 28.
  53. “Fats and fatty acids in human nutrition: report of an expert consultation”. Rome: FAO (2010).
  54. Hixson SM., et al. “Long-chain omega-3 polyunsaturated fatty acids have developmental effects on the crop pest, the cabbage white butterfly Pieris rapae”. PLOS ONE 11 (2016): e0152264.
  55. Zirpoli H., et al. “Novel approaches for omega-3 fatty acid therapeutics: chronic versus acute administration to protect heart, brain, and spinal cord”. Annual Review of Nutrition 21 (2020): 161-187.
  56. Waliullah S., et al. “Prevalence of primary post-menopausal osteoporosis at various sites in Indian females”. International Journal of Health Sciences and Research8 (2014): 113-117.
  57. Tan A., et al. “Supplementation with eicosapentaenoic acid and docosahexaenoic acid reduces high levels of circulating proinflammatory cytokines in aging adults: a randomized, controlled study”. Prostaglandins, Leukotrienes and Essential Fatty Acids 132 (2018): 23-29.
  58. Zúñiga J., et al. “N-3 PUFA supplementation triggers PPAR-α activation and PPAR-α/NF-κB interaction: anti-inflammatory implications in liver ischemia reperfusion”. Injury 6 (2011): 28502.
  59. Duda MK., et al. “Dietary supplementation with ω-3 PUFA increases adiponectin and attenuates ventricular remodeling and dysfunction with pressure overload”. Cardiovascular Research 76 (2007): 303-310.
  60. Kiecolt-Glaser., et al. “Omega-3 supplementation lowers inflammation in healthy middle-aged and older adults: A randomized controlled trial”. Brain, Behavior, and Immunity 26 (2012): 988-995.
  61. Bentsen H. “Dietary polyunsaturated fatty acids, brain function and mental health”. Microbial Ecology in Health and Disease 28 (2017): 1281916.
  62. Ara Z., et al. “Impact on Musculoskeletal after Spinal Cord Injury”. International Journal of Molecular Biology and Biochemistry1 (2022): 1-22.
  63. King VR., et al. “Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat”. Journal of Neuroscience 26 (2006): 4672-80.
  64. Bi J., et al. “Neuroprotective effect of omega‐3 fatty acids on spinal cord injury induced rats”. Brain and Behavior 9 (2019): 01339.
  65. Baazm M., et al. “Regulation of Inflammasomes by Application of Omega-3 Polyunsaturated Fatty Acids in a Spinal Cord Injury Model”. Cells 10 (2021): 3147.
  66. Mahadewa Tjokorda GB., et al. “The difference in motor improvements related to combination of omega-3 polyunsaturated fatty acid and alpha-tocopherol supplementations diet of weight-dropped induced spinal cord injury in rats”. Bali Medical Journal 3 (2017): 22.
  67. Puri BK., et al. “MRI and neuropsychological improvement in Huntington disease following ethyl-EPA treatment”. NeuroReport 13 (2002): 123-126.
  68. Zanarini MC and Frankenburg FR. “Omega-3 fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study”. The American Journal of Psychiatry 160 (2003): 67-169.
  69. SN Lim., et al. “Transgenic mice with high endogenous omega-3 fatty acids are protected from spinal cord injury”. Neurobiology of Disease 51 (2013): 104-112.
  70. Javidan AN., et al. “Does consumption of polyunsaturated fatty acids influence on neuro rehabilitation in traumatic spinal cord-injured individuals? a double-blinded clinical trial”. Spinal Cord5 (2014): 378-382.
  71. ST Emon., et al. “Effects of parenteral nutritional support with fish-oil emulsion on spinal cord recovery in rats with traumatic spinal cord injury”. Turkish Neurosurgery3 (2010): 537-547.
  72. Ward RE., et al. “Docosahexaenoic acid prevents white matter damage after spinal cord injury”. Journal of Neurotrauma 27 (2010): 1769-1780.
  73. Chen WF., et al. “Neuroprotective Effects of Direct Intrathecal Administration of Granulocyte Colony-Stimulating Factor in Rats with Spinal Cord Injury”. CNS Neuroscience and Therapeutics 21 (2015): 698-707.
  74. Mills JD., et al. “Omega-3 fatty acid supplementation and reduction of traumatic axonal injury in a rodent head injury model”. Journal of Neurosurgery1 (2011): 77-84.
  75. Paterniti I., et al. “Docosahexaenoic acid attenuates the early inflammatory response following spinal cord injury in mice: in-vivo and in-vitro studies”. Journal of Neuroinflammation (2014): 1-8.
  76. Schwab JM and Zhang. “The paradox of chronic neuroinflammation, systemic immune suppression, autoimmunity after traumatic chronic spinal cord injury”. Experimental Neurology 258 (2014): 121-129.
  77. Yune TY., et al. “Increased production of tumor necrosis factor-alpha induces apoptosis after traumatic spinal cord injury in rats”. Journal of Neurotrauma 20 (2003): 207-219.

Citation

Citation: Rajeshwar Nath Srivastava., et al. “Epidemology and Pathophysiology of Spinal Cord Injury and Potential Health Benefits of Omega 3 Fatty Acid”.Acta Scientific Orthopaedics 6.1 (2023): 143-156.

Copyright

Copyright: © 2023 Rajeshwar Nath Srivastava., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate33%
Acceptance to publication20-30 days

Indexed In



News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US